KRSNAA DIAGNOSTICS
|
KRSNAA DIAGNOSTICS Last 5 Year Financial Ratios History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | |
---|---|---|---|
Operational & Financial Ratios | |||
Earnings Per Share (Rs) | 17.60 | 19.78 | 21.78 |
CEPS(Rs) | 40.69 | 36.91 | 34.96 |
DPS(Rs) | 2.50 | 2.75 | 2.50 |
Book NAV/Share(Rs) | 250.05 | 234.43 | 217.33 |
Tax Rate(%) | 18.81 | 22.56 | 20.95 |
Margin Ratios | |||
Core EBITDA Margin(%) | 23.28 | 25.11 | 28.87 |
EBIT Margin(%) | 13.96 | 18.04 | 23.05 |
Pre Tax Margin(%) | 11.30 | 16.46 | 18.99 |
PAT Margin (%) | 9.17 | 12.75 | 15.02 |
Cash Profit Margin (%) | 21.20 | 23.79 | 24.10 |
Performance Ratios | |||
ROA(%) | 5.47 | 6.96 | 7.81 |
ROE(%) | 7.36 | 8.76 | 10.02 |
ROCE(%) | 9.94 | 11.75 | 14.47 |
Asset Turnover(x) | 0.60 | 0.55 | 0.52 |
Sales/Fixed Asset(x) | 0.83 | 0.87 | 0.93 |
Working Capital/Sales(x) | 4.43 | 3.94 | 2.14 |
Efficiency Ratios | |||
Fixed Capital/Sales(x) | 1.21 | 1.15 | 1.08 |
Receivable days | 73.45 | 49.07 | 46.38 |
Inventory Days | 17.93 | 12.83 | 7.35 |
Payable days | 186.90 | 343.02 | 467.93 |
Valuation Parameters | |||
PER(x) | 34.93 | 23.26 | 22.29 |
PCE(x) | 15.11 | 12.47 | 13.89 |
Price/Book(x) | 2.46 | 1.96 | 2.23 |
Yield(%) | 0.41 | 0.60 | 0.51 |
EV/Net Sales(x) | 3.38 | 2.81 | 2.91 |
EV/Core EBITDA(x) | 12.99 | 9.66 | 9.04 |
EV/EBIT(x) | 24.18 | 15.57 | 12.61 |
EV/CE(x) | 2.16 | 1.77 | 1.51 |
M Cap / Sales | 3.20 | 2.97 | 3.35 |
Growth Ratio | |||
Net Sales Growth(%) | 27.20 | 6.95 | - |
Core EBITDA Growth(%) | 13.67 | -3.22 | - |
EBIT Growth(%) | -1.60 | -16.29 | - |
PAT Growth(%) | -8.49 | -9.18 | - |
EPS Growth(%) | -11.02 | -9.18 | - |
Financial Stability Ratios | |||
Total Debt/Equity(x) | 0.20 | 0.04 | 0.06 |
Current Ratio(x) | 1.50 | 2.25 | 2.76 |
Quick Ratio(x) | 1.37 | 1.99 | 2.69 |
Interest Cover(x) | 5.25 | 11.42 | 5.68 |
Total Debt/Mcap(x) | 0.08 | 0.02 | 0.03 |
Compare Financial Ratios of peers of KRSNAA DIAGNOSTICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KRSNAA DIAGNOSTICS | ₹2,795.2 Cr | -5.3% | -6.5% | 17.9% | Stock Analytics | |
MAX HEALTHCARE INSTITUTE | ₹105,656.0 Cr | -9.6% | -7.9% | 47.3% | Stock Analytics | |
APOLLO HOSPITALS ENTERPRISE | ₹96,403.3 Cr | -6.1% | -7.7% | 18% | Stock Analytics | |
FORTIS HEALTHCARE | ₹50,102.8 Cr | -8.4% | -6.8% | 56.8% | Stock Analytics | |
GLOBAL HEALTH | ₹27,712.8 Cr | -4.4% | -7.4% | 3.3% | Stock Analytics | |
NARAYANA HRUDAYALAYA | ₹26,394.2 Cr | -5.4% | 0.3% | 2.6% | Stock Analytics |
KRSNAA DIAGNOSTICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KRSNAA DIAGNOSTICS | -5.3% |
-6.5% |
17.9% |
SENSEX | -2.2% |
-5.9% |
7.2% |
You may also like the below Video Courses